
I initiate Yuanbao Inc. with a Buy rating after evaluating its performance and outlook. YB's 33% bottom-line expansion for 2Q2026 was driven by supportive Chinese insurance policies, and AI-driven cost efficiencies. The commitment to progressive cash payouts sends a positive signal about management's confidence in future prospects.










